index - Génétique et physiopathologie des MNM liées à la matrice extracellulaire et du noyau Accéder directement au contenu

Dernières publications

Chiffres clés

120 Publications avec texte intégral
1 Données de recherche

Open Access

47 %

Mots clés

Myologie Emerin Congenital muscular dystrophy Neuromuscular diseases Becker muscular dystrophy Lamin A/C Dynamin 2 Emery-Dreifuss muscular dystrophy Centronuclear myopathy Skeletal muscle Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS COL6A1 BiP Butyrylcholinesterase A-type lamin Hypermobile EDS LMNA-related congenital muscular dystrophy Laminopathies LGMD A-type lamins Cancer Mutations Alternative splicing Laminopathy Lamins Autophagosome maturation Maladies rares et orphelines Diagnosis Actionability CRISPR Lamin A/C LMNA gene Errance diagnostique Therapy AAV VECTOR Myopathy Base de données FAIR Heart Connective tissue Next generation sequencing Ehlers‐Danlos Syndrome RNA interference Biological sciences GNE C elegans Dystrophine Gene therapy Rare neuromuscular diseases Maladies rares Muscular dystrophy Rare diseases Muscle Myotubes COL6A3 Collagen VI-related myopathies NGS collagen type VI congenital muscular dystrophy CMD limb-girdle muscular dystrophy LGMD muscular MRI neuromuscular disorders Treatment Cardiology AAV Patient registry Calcium handling Biomarker Nuclear envelope C2C12 INPP5K Dystrophie musculaire POPDC1 Myopathies CSF protein Treatment delay LMNA gene Exome Lamin A/C nuclei Joint laxity Angiotensin-converting enzyme inhibitor Muscle MRI Regeneration IPSC Muscular dystrophy MD Actionable gene Adult SMA Heart failure Duchenne muscular dystrophy Titin Dilated cardiomyopathy Muscle biopsy LMNA COL1A1 Cancer biomarkers Allele‐specific silencing therapy Allele-specific silencing Cardiac conduction system Cardiomyopathy CMTX Laminopathie COVID-19 BVES Acetyltransferase Clinical trial Allele-specific silencing therapy Angiotensin-converting enzyme inhibitors Mouse Myogenesis